Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Infectious diseases
- Bacterial diseases
- Steps to an infection
- Bacterial pathogenesis
- Introduction to toxins
- Exotoxin
- Endotoxins
- Mechanisms of adherence
- Electron microscope image of pili
- BFP and adhesion
- Type III secretion systems
- Pathogenic E.Coli - O157
- Type III secretion in E. Coli O157 (1)
- Type III secretion in E. Coli O157 (2)
- Translocon and effector proteins
- Model of EPEC pedestal formation
- Cytoskeletal proteins recruited to the pedestal
- E. coli - induced cytoskeletal rearrangements
- TIR delivery to host cell via type III system
- Life inside a host cell - intracellular pathogens
- Intracellular survival strategies
- Salmonella enterica
- Salmonella - an intracellular pathogen
- Salmonella typhimurium
- Salmonella's two type III secretion systems
- Salmonella invasion (1)
- Salmonella invasion (2)
- SCV trafficking in epithelial cells
- Intracellular Salmonella
- Salmonella evade host defenses
- Intracellular Listeria monocytogenes
- Listeria intracellular movement
- Regulation of virulence factors
- Avoiding innate defenses
- Avoiding acquired immunity
- Anti-phagocytosis
- Yersinia inhibition of phagocytosis
- Role of the microbiota
- Microbiota disturbed in Citrobacter infection
- Antibiotics
- Antibiotic mechanisms
- Superbugs
- Vaccines
- Top four bioterrorist diseases
- Conclusions
Topics Covered
- Overview of bacterial diseases and virulence factors
- Toxins
- Adherence mechanisms
- Type III secretion systems
- Intracellular survival mechanisms
- Avoiding the immune system
- Impact of microbiota
- Antibiotics
- Vaccines -Bioterrorism
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Finlay, B.B. (2009, October 29). The molecular basis of bacterial pathogenicity: an overview [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 23, 2024, from https://doi.org/10.69645/RFAL4387.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. B. Brett Finlay has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Infectious Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
Hi. My name is Brett Finlay.
I'm the series editor
for this section of
the Henry Stewart Talks entitled
"The Molecular Basis of
Bacterial Pathogenicity".
In addition to compiling the
various invited speakers,
my job for this lecture
is to overview at
a molecular basis how
bacteria cause disease.
This is obviously a
very large subject.
In this lecture, I will just
highlight some of the
areas that you can expect
to find in some of
the more specialized
talks in this series.
0:32
As we know infectious diseases
continues to plague the world.
At least a third of all
deaths worldwide are due to
some infectious agent and these
are not confined to the
developing countries.
In developed countries,
we see one in
five deaths due to
an infectious agent.
Compiling this are the
newly emerging organisms,
the re-emerging diseases,
and the potential of
bioterrorism-type agents.
Thus infectious
diseases including
bacterial diseases
continue to plague
this world and we
continue to strive to
ways to combat these agents.
1:11
It is thought that at
least 100 bacteria have
the potential to cause
specific diseases in humans.
On this slide is a
long list of some of
the bacterial cause diseases
that we encounter as humans.
We will not go through
these individual diseases
but I illustrate
the complexity and diversity
of diseases caused by
bacterial pathogens.
1:37
The question is how do
bacteria actually cause
these diseases and what kind of
molecular tools do they use
to achieve these effects?
If one is to consider how an
infection actually occurs,
there are several
steps that a pathogen
goes through before we
ultimately see disease.
At each of these steps,
bacterial pathogens have
evolved specific factors called
virulence factors
that allow them
to proceed through particular
steps of infection.
The first steps are
the initiation of the
exposure to the pathogen.
That is you may swallow
an organism or it may
contact your skin or
wherever on the body.
To be successful a pathogen
has to recognize that site
and ideally set up a
colonization at that point.
This can be specific adherents
say to mucosal surface
or it can even go on to
dig deeper in the tissues,
that is invade and penetrate
through the epithelium
and then going on to spread
to further sites in the body.
A key aspect of
micropathogenesis is
the ability of the pathogen
to grow and increase in numbers.
The pathogen enters as one
and does not replicate.
You can imagine that does
not cause further disease.
There are several side effects
that this pathogen causes in
the host and this is often
represented by the actual
presentation of disease.
This is often due to
various detrimental effects to
the host such as tissue damage,
inflammation, et cetera
and this is what
we see as bacterial disease.